American Oncology Network, Inc.
AONCDelisted- Industry
- Services-Health Services
- SEC CIK
- 0001839998
American Oncology Network, Inc. was delisted in 2026; its insiders filed their last Form 4 on Jul 18, 2024; 1 institution reported holding it in 13F filings for Q1 2026, worth $325.2K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by American Oncology Network, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for American Oncology Network, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Fluegel Bradley M | Director | 44,981 | Jul 18, 2024 | 0 |
| Afshar David | Chief Financial Officer | 150,000 | Jul 18, 2024 | 0 |
| Divers Stephen | Chief Medical Officer | 98,470 | Jul 18, 2024 | 0 |
| Schonherz Todd | Chief Executive Officer | 305,340 | Jul 18, 2024 | 0 |
| Mallon Erica | General Counsel | 36,000 | Jul 18, 2024 | 0 |
| Valle William | Director | 19,981 | Jul 18, 2024 | 0 |
| American Oncology Network, Inc. | Chief Medical Officer | 9,893 | Jan 5, 2024 | 0 |
| Digital Transformation Sponsor LLC | 10% Owner | 5,273,125 | Sep 29, 2023 | 0 |
| Nazemi Kevin | 10% Owner | 5,273,125 | Sep 29, 2023 | 0 |
| Saba Capital Management, L.P. | 10% Owner | 0Indirect | Sep 25, 2023 | 0 |
| Weinstein Boaz | 10% Owner | 0Indirect | Sep 25, 2023 | 0 |
| Hoesterey Brian R | 10% Owner | – | Sep 22, 2023 | 0 |
| Aea Growth Equity Fund (Parallel) LP | 10% Owner | – | Sep 22, 2023 | 0 |
| Aea Growth Equity Fund LP | 10% Owner | – | Sep 22, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2024 (view filing) | May 24 | 6 daysLate | Divers StephenChief Medical Officer | PPurchaseClass A Common Stock | +5.00K | $2.15 | +$10.8K | +8.7%62.5K after | |
| May 30, 2024 (view filing) | May 21 | 9 daysLate | Schonherz ToddChief Executive Officer | PPurchaseClass A Common Stock | +5.34K | $1.87 | +$9.96K | New position5.34K after | 3 lots |
| Sep 25, 2023 (view filing)5:59 PM ET | Sep 25 | Same day | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −205.5K | $10.50 | −$2.16M | −100.0%0 after |